An advocacy group including Leukaemia & Blood Cancer New Zealand, Myeloma New Zealand, Chronic Lymphocytic Leukaemia Advocates New Zealand, as well as consultant haematologists – seeks urgent assurance of timely access to effective blood cancer medicines following ...
